Edesa Biotech

EDSANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$46.861 M

$5.27 +4.36%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$7.19M

Loss-making

Shares outstanding

8,891,951

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#354Karyopharm TherapeuticsKPTI$48.0M
#355Impact BiomedicalIBO$46.9M
#356Edesa BiotechEDSA$46.9M
#357Mereo BioPharma GroupMREO$46.0M
#358Context TherapeuticsCNTX$44.5M

Where these numbers come from

Share counts and financials for Edesa Biotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.